How a Pharmaceutical Company Steamlined Insight Delivery | Techspert
A global pharmaceutical company with a 50+ medicine portfolio and distribution across 50+ countries, and up to $1bn in yearly revenues, strengthened its insight-generation ...
Success Stories, Healthcare and Life Sciences, Oncology
Find out how a consultancy used primary market research to generate recommendations on how to improve the ovarian cancer patient journey.
Ovarian cancer (OC) is the seventh most common cancer and the eighth most common cause of cancer death in women worldwide¹, with the disease generally advanced at diagnosis due to its non-specific symptoms.
We supported our consultancy customer with primary market research in this disease area, recruiting nurses and physicians in the US, EU and Japan.
The purpose of this project was to identify and understand the challenges across the patient journey from an emotional perspective, in order to generate recommendations for the research sponsor on how to improve it.
Several recurring themes were identified for the research sponsor, including:
OC has non-specific symptoms, so diagnosis can go on for years. Symptoms including nausea and bloating can be easily dismissed as a GI issue. Initial misdiagnosis can lead patients to feel mistrust in their healthcare system within the first stages of their journey.
Following the expert engagements we facilitated, the customer developed a better understanding of investment plans in green energy projects and the technology to manage them. This enabled the customer to present their end client with recommendations informed by subject-domain experts which their end client used to inform their decision-making.
Some of the experts the customer engaged with included:
1. World Cancer Research Fund- American Institute for Cancer Research
A global pharmaceutical company with a 50+ medicine portfolio and distribution across 50+ countries, and up to $1bn in yearly revenues, strengthened its insight-generation ...
See how this Biopharma used Techspert to rapidly source the right experts and validate their opportunity, build a study proposal to take to the FDA, and bypass a six-month ...
Find out how Techspert connected Putnam Associates with infectious disease specialists, enabling them to successfully expand their client's anti-infective portfolio into new ...